Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...
Denali Therapeutics' experimental drug for amyotrophic ... and generic drug riluzole (sold as Rilutek by Sanofi), and Biogen's Qalsody (tofersen), the latter only if they have a genetic form ...
A resolution was passed Friday by the Alaska Legislature urging President Donald Trump to reverse course and retain the name of North America's tallest peak as Mount Denali. AP The Alaska ...
JUNEAU, Alaska (AP) — The Alaska Legislature passed a resolution Friday urging President Donald Trump to reverse course and retain the name of North America’s tallest peak as Denali rather ...
JUNEAU, Alaska (AP) — The Alaska Legislature passed a resolution Friday urging President Donald Trump to reverse course and retain the name of North America’s tallest peak as Denali rather ...
Copyright 2025 The Associated Press. All Rights Reserved. People stand at the Eielson Visitor Center with a view of North America’s tallest peak, Denali, in the ...
In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry ...
Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...
Biogen Pharmachem Industries Ltd share price was down by -0.86% from the previous closing price of ₹1.16. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback